Antioxidant protection in patients with pulmonary tuberculosis

Keywords: pulmonary tuberculosis, anti-tuberculosis drugs, lipid peroxidation, antioxidant protection


The literature review summarizes the data on the classification and characteristics of the antioxidant defense system. This model combines a number of different substances. Each of the components of the antioxidant system acts in close connection with its other structural elements, harmoniously complements, and in many cases – enhances the action of each other.

The functional basis of the system of antioxidant protection is formed by the glutathione system, the constituent elements of which are actually glutathione and enzymes that catalyze the reactions of its reverse transformation (oxidation ↔ reduction). Most researchers conventionally divide the system of antioxidant protection into enzymatic and non-enzymatic. The enzyme links of the antioxidant defense system include: catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase and other enzymes. The non-enzymatic system includes fat-soluble vitamins A, E and K, water-soluble vitamins C and PP, biogenic amines, glutathione, carotenoids, ubiquinone, sterols.

Both enzymatic and non-enzymatic antioxidant defense systems are present in the bloodstream. The activity of the enzymatic antioxidant system is very well regulated and depends on age, physiological condition, hormone dynamics, intensity of antioxidant enzyme synthesis, pH, presence of coenzymes, inhibitors, activators and other factors. The non-enzymatic part of the antioxidant system does not require as many regulators as the chemical itself - the antioxidant - reacts chemically with the radical. Only the reaction rate can change.

The lungs are directly exposed to oxygen and oxidants of polluted air, they are most sensitive to oxidative damage, so they have an increased possibility of free radical reactions. Protection against the damaging effects of reactive oxygen species and free radicals is provided by anti-radical protective systems, especially the glutathione system and its enzymes. Numerous papers have obtained clinical and experimental data on the important role of free radical oxidation of lipids (FROL) and antioxidant systems (AOS) protection in the development of many diseases, including pulmonary tuberculosis (TB).

The review presents modern views on the state of the system of lipid peroxidation (LPO) and antioxidant protection in TB. The main topic of the review is information on the generation of free radical compounds by different populations of leukocytes with further enhancement of LPO and secondary deepening of functional disorders. The article substantiates the feasibility of identifying LPO products as non-specific markers of aseptic inflammation in TB and the need to develop new generations of antioxidants.

One of the universal mechanisms of damage to cell membranes is LPO, the excessive activation of which is normally prevented by factors of the antioxidant defense system. Membrane-bound enzymes involved in the formation of LPO products include lipoxy and cyclooxygenases. Lipoperoxidation processes change the structure and phospholipid composition of cell membranes, which negatively affects the cellular immune response due to damage to the mechanisms of information transfer from extracellular regulators to intracellular effector systems.


Download data is not yet available.

Author Biography

Viktor Slivka, Bukovinian State Medical University

MD, PhD, Associate Professor of the Department of Phthisiology and Pulmonology, Bukovinian State Medical University, 2, Teatralna av., Chernivtsi, Ukraine, 58000


Hernandez-Pando R, Orozco H, Arriaga K, Sampieri A, Larriva-Sahd J, Madrid-Marina V. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology. 1997 Apr; 90 (4): 607–17. doi: 10.1046/j.1365-2567.1997.00193.x. PMID: 9176116; PMCID: PMC1456699.

Boisson-Dupuis S. The monogenic basis of human tuberculosis. Hum Genet. 2020 Jun; 139 (6-7): 1001–1009. Epub 2020 Feb 13. PMID: 32055999; PMCID: PMC7275886.

Cai Y, Dai Y, Wang Y, Yang Q, Guo J, Wei C, Chen W, Huang H, Zhu J, Zhang C, Zheng W, Wen Z, Liu H, Zhang M, Xing S, Jin Q, Feng CG, Chen X. Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis. EBioMedicine. 2020 Mar; 53:102686. Epub 2020 Feb 27. PMID: 32114394; PMCID: PMC7047188.

Shichi I, Sato A, Chida K, Yasuda K, Tatsuta Y, Honda A, Wada R, Yamazaki A. [Chemotherapeutic evaluation of pulmonary tuberculosis patients with a complication of hepatic dysfunction]. Kekkaku. 1991 Apr;66(4):309-17. Japanese. PMID: 2051706.

Dharmaraja AT. Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria. J Med Chem. 2017 Apr 27; 60 (8): 3221–3240. Epub 2017 Feb 14. PMID: 28135088.

Eribo OA, du Plessis N, Ozturk M, Guler R, Walzl G, Chegou NN. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty? Cell Mol Life Sci. 2020 Apr; 77 (8): 1497–1509. Epub 2019 Nov 15. PMID: 31729564; PMCID: PMC7162824.

Guo Q, Li F, Duan Y, Wen C, Wang W, Zhang L, Huang R, Yin Y. Oxidative stress, nutritional antioxidants and beyond. Sci China Life Sci. 2020 Jun; 63 (6): 866–874. Epub 2019 Nov 5. PMID: 31705360.

Schuiling M, Zuidhof AB, Zaagsma J, Meurs H. Involvement of tachykinin NK1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea pigs. Am J Respir Crit Care Med. 1999 Feb; 159 (2): 423–30. doi: 10.1164/ajrccm.159.2.9804125. PMID: 9927353.

Jakubczyk K, Kałduńska J, Dec K, Kawczuga D, Janda K. Antioxidant properties of small-molecule non-enzymatic compounds. Pol Merkur Lekarski. 2020 Apr 22; 48 (284): 128–132. PMID: 32352947.

Ko DH, Lee EJ, Lee SK, Kim HS, Shin SY, Hyun J, Kim JS, Song W, Kim HS. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation. Ann Clin Microbiol Antimicrob. 2019 Jan 3; 18 (1): 2. PMID: 30606210; PMCID: PMC6317249.

Kulkarni RA, Deshpande AR. Anti-inflammatory and antioxidant effect of ginger in tuberculosis. J Complement Integr Med. 2016 Jun 1; 13 (2): 201–6. PMID: 27089418

Liu Y , Gao L , Yi J , Fan Y , Wu X , Zhang Y. α-Lactalbumin and chitosan core-shell nanoparticles: resveratrol loading, protection, and antioxidant activity. Food Funct. 2020 Feb 26; 11 (2): 1525–1536. PMID: 31995080.

Maqsoudlou A, Assadpour E, Mohebodini H, Jafari SM. Improving the efficiency of natural antioxidant compounds via different nanocarriers. Adv Colloid Interface Sci. 2020 Apr; 278: 102122. Epub 2020 Feb 11. PMID: 32097732.

Mishra BB, Lovewell RR, Olive AJ, Zhang G, Wang W, Eugenin E, Smith CM, Phuah JY, Long JE, Dubuke ML, Palace SG, Goguen JD, Baker RE, Nambi S, Mishra R, Booty MG, Baer CE, Shaffer SA, Dartois V, McCormick BA, Chen X, Sassetti CM. Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nat Microbiol. 2017 May 15; 2: 17072. PMID: 28504669; PMCID: PMC5461879.

Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci. 1991;14:123-36. doi: 10.1146/ PMID: 1851606.

Osei Sekyere J, Maningi NE, Fourie PB. Mycobacterium tuberculosis, antimicrobials, immunity, and lung-gut microbiota crosstalk: current updates and emerging advances. Ann N Y Acad Sci. 2020 May;1467 (1): 21–47. Epub 2020 Jan 28. PMID: 31989644.

Pi J, Shen L, Yang E, Shen H, Huang D, Wang R, Hu C, Jin H, Cai H, Cai J, Zeng G, Chen ZW. Macrophage-Targeted Isoniazid-Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli. Angew Chem Int Ed Engl. 2020 Feb 17;59(8):3226-3234. Epub 2020 Jan 16. PMID: 31756258.

Proskurnina EV, Izmailov DY, Sozarukova MM, Zhuravleva TA, Leneva IA, Poromov AA. Antioxidant Potential of Antiviral Drug Umifenovir. Molecules. 2020 Mar 30; 25 (7): 1577. PMID: 32235534; PMCID: PMC7181215.

Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol. 1992 Oct;90(4 Pt 1):646-52. PMID: 1383307.

Yang H, Chen J, Chen Y, Jiang Y, Ge B, Hong L. Sirtuin inhibits M. tuberculosis -induced apoptosis in macrophage through glycogen synthase kinase-3β. Arch Biochem Biophys. 2020 Nov 15; 694:108612. Epub 2020 Sep 29. PMID: 33007281.

Bazhora Yu.I., Ermeraki PP, Smetyuk EA, Chesnokova MM Glutathione-dependent enzyme system in patients with pulmonary tuberculosis // Bulletin of readings im. V.V. Podvysotsky. Odessa, May 26-27, 2016 - Odessa, 2016. - P. 18-19

Ermuraki PP, Smetyuk OO Activity of glutathione peroxidase and glutathione reductase in patients with pulmonary tuberculosis before and after treatment // All-Ukrainian scientific-practical conference of young scientists and students of international. participation, dedicated. Science Day, Zaporizhia, May 12-13. 2016 - Zaporozhye, 2016. - P. 22.

How to Cite
Slivka, V. (2021). Antioxidant protection in patients with pulmonary tuberculosis. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (41).